|
Product Information |
|
Product name |
Trilostane |
|
CAS No. |
13647-35-3 |
|
Molecular Formula |
C20H27NO3 |
|
Molecular Weight |
329.43 |
|
Quality Standard |
98.0% up by HPLC |
|
Appearance |
White or almost white powder |
|
COA |
|
ANALYSIS |
SPECIFICATION |
RESULTS |
|
Appearance |
White or almost white powder |
Almost white powder |
|
Identification IR |
The infrared absorption spectrum of the sample is concordant with the reference spectrum |
Conforms |
|
Specific optical rotation |
+137 to +139 |
+139 |
|
Loss on drying |
≤0.5% |
0.41% |
|
Heavy metals |
≤20ppm |
<20ppm |
|
Residue on ignition |
≤0.1% |
0.06% |
|
Related substances |
Any impurity ≤ 0.5% |
0.05% |
|
Total impurities ≤ 1.0% |
0.19% |
|
|
Residual solvents |
Ethanol ≤ 5000ppm |
175 ppm |
|
Dichloromethane ≤ 600ppm |
Not detected |
|
|
Ethyl acetate ≤ 5000ppm |
Not detected |
|
|
Ethyl formate ≤ 5000ppm |
Not detected |
|
|
Dimethyl sulfoxide ≤ 5000ppm |
4245ppm |
|
|
Purity |
≥99.0% |
99.8% |
|
Assay((on dried bases) |
980% - 102.0% |
98.8% |
|
Conclusion |
The product meets the in-house standard |
|
|
Usage |
What is Trilostane?
Trilostane is primarily used in veterinary medicine to treat Cushing's syndrome (hyperadrenocorticism) in dogs.Trilostane works by inhibiting an enzyme called 3-beta-hydroxysteroid dehydrogenase, which is involved in the production of cortisol. By blocking this enzyme, Trilostane helps reduce the production of cortisol, alleviating the symptoms associated with Cushing's syndrome in dogs.
*Products under the patent are only for R&D use